Clinical Trial Update: Chidamide Combined With Sintilimab and Bevacizumab for the First-line Treatment of Advanced Liver Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating chidamide in combination with sintilimab and bevacizumab as first-line therapy for advanced hepatocellular carcinoma; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Avastin (bevacizumab) (bevacizumab)
• Chidamide (chidamide)
• Tyvyt (Sintilimab) (Sintilimab)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Liver Cancer | Phase 2 | Status: NOT_YET_RECRUITING